Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Parkinson's Disease Market Growth (Status and Outlook) 2022-2028

  • LP 4874265
  • 100 Pages
  • February 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Parkinson's Disease will have significant change from previous year. According to our (LP Information) latest study, the global Parkinson's Disease market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Parkinson's Disease market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Parkinson's Disease market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Parkinson's Disease market, reaching US$ million by the year 2028. As for the Europe Parkinson's Disease landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Parkinson's Disease players cover Teva, Novartis, GSK, and AbbVie, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson's Disease market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Carbidopa/Levodopa

Dopamine Receptor Agonists

MAO-Inhibitors

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals

Clinics

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Teva

Novartis

GSK

AbbVie

Merck

Boehringer Ingelheim

Amneal + Impax

Lundbeck

Sun Pharma

Wockhardt

UCB

Bausch Health

Acadia

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Parkinson's Disease Market Size 2017-2028

2.1.2 Parkinson's Disease Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Parkinson's Disease Segment by Type

2.2.1 Carbidopa/Levodopa

2.2.2 Dopamine Receptor Agonists

2.2.3 MAO-Inhibitors

2.3 Parkinson's Disease Market Size by Type

2.3.1 Parkinson's Disease Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Parkinson's Disease Market Size Market Share by Type (2017-2022)

2.4 Parkinson's Disease Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.5 Parkinson's Disease Market Size by Application

2.5.1 Parkinson's Disease Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Parkinson's Disease Market Size Market Share by Application (2017-2022)

3 Parkinson's Disease Market Size by Player

3.1 Parkinson's Disease Market Size Market Share by Players

3.1.1 Global Parkinson's Disease Revenue by Players (2020-2022)

3.1.2 Global Parkinson's Disease Revenue Market Share by Players (2020-2022)

3.2 Global Parkinson's Disease Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Parkinson's Disease by Regions

4.1 Parkinson's Disease Market Size by Regions (2017-2022)

4.2 Americas Parkinson's Disease Market Size Growth (2017-2022)

4.3 APAC Parkinson's Disease Market Size Growth (2017-2022)

4.4 Europe Parkinson's Disease Market Size Growth (2017-2022)

4.5 Middle East & Africa Parkinson's Disease Market Size Growth (2017-2022)

5 Americas

5.1 Americas Parkinson's Disease Market Size by Country (2017-2022)

5.2 Americas Parkinson's Disease Market Size by Type (2017-2022)

5.3 Americas Parkinson's Disease Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Parkinson's Disease Market Size by Region (2017-2022)

6.2 APAC Parkinson's Disease Market Size by Type (2017-2022)

6.3 APAC Parkinson's Disease Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Parkinson's Disease by Country (2017-2022)

7.2 Europe Parkinson's Disease Market Size by Type (2017-2022)

7.3 Europe Parkinson's Disease Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Parkinson's Disease by Region (2017-2022)

8.2 Middle East & Africa Parkinson's Disease Market Size by Type (2017-2022)

8.3 Middle East & Africa Parkinson's Disease Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Parkinson's Disease Market Forecast

10.1 Global Parkinson's Disease Forecast by Regions (2023-2028)

10.1.1 Global Parkinson's Disease Forecast by Regions (2023-2028)

10.1.2 Americas Parkinson's Disease Forecast

10.1.3 APAC Parkinson's Disease Forecast

10.1.4 Europe Parkinson's Disease Forecast

10.1.5 Middle East & Africa Parkinson's Disease Forecast

10.2 Americas Parkinson's Disease Forecast by Country (2023-2028)

10.2.1 United States Parkinson's Disease Market Forecast

10.2.2 Canada Parkinson's Disease Market Forecast

10.2.3 Mexico Parkinson's Disease Market Forecast

10.2.4 Brazil Parkinson's Disease Market Forecast

10.3 APAC Parkinson's Disease Forecast by Region (2023-2028)

10.3.1 China Parkinson's Disease Market Forecast

10.3.2 Japan Parkinson's Disease Market Forecast

10.3.3 Korea Parkinson's Disease Market Forecast

10.3.4 Southeast Asia Parkinson's Disease Market Forecast

10.3.5 India Parkinson's Disease Market Forecast

10.3.6 Australia Parkinson's Disease Market Forecast

10.4 Europe Parkinson's Disease Forecast by Country (2023-2028)

10.4.1 Germany Parkinson's Disease Market Forecast

10.4.2 France Parkinson's Disease Market Forecast

10.4.3 UK Parkinson's Disease Market Forecast

10.4.4 Italy Parkinson's Disease Market Forecast

10.4.5 Russia Parkinson's Disease Market Forecast

10.5 Middle East & Africa Parkinson's Disease Forecast by Region (2023-2028)

10.5.1 Egypt Parkinson's Disease Market Forecast

10.5.2 South Africa Parkinson's Disease Market Forecast

10.5.3 Israel Parkinson's Disease Market Forecast

10.5.4 Turkey Parkinson's Disease Market Forecast

10.5.5 GCC Countries Parkinson's Disease Market Forecast

10.6 Global Parkinson's Disease Forecast by Type (2023-2028)

10.7 Global Parkinson's Disease Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Teva

11.1.1 Teva Company Information

11.1.2 Teva Parkinson's Disease Product Offered

11.1.3 Teva Parkinson's Disease Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Teva Main Business Overview

11.1.5 Teva Latest Developments

11.2 Novartis

11.2.1 Novartis Company Information

11.2.2 Novartis Parkinson's Disease Product Offered

11.2.3 Novartis Parkinson's Disease Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Novartis Main Business Overview

11.2.5 Novartis Latest Developments

11.3 GSK

11.3.1 GSK Company Information

11.3.2 GSK Parkinson's Disease Product Offered

11.3.3 GSK Parkinson's Disease Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 GSK Main Business Overview

11.3.5 GSK Latest Developments

11.4 AbbVie

11.4.1 AbbVie Company Information

11.4.2 AbbVie Parkinson's Disease Product Offered

11.4.3 AbbVie Parkinson's Disease Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 AbbVie Main Business Overview

11.4.5 AbbVie Latest Developments

11.5 Merck

11.5.1 Merck Company Information

11.5.2 Merck Parkinson's Disease Product Offered

11.5.3 Merck Parkinson's Disease Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Merck Main Business Overview

11.5.5 Merck Latest Developments

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Information

11.6.2 Boehringer Ingelheim Parkinson's Disease Product Offered

11.6.3 Boehringer Ingelheim Parkinson's Disease Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Boehringer Ingelheim Main Business Overview

11.6.5 Boehringer Ingelheim Latest Developments

11.7 Amneal + Impax

11.7.1 Amneal + Impax Company Information

11.7.2 Amneal + Impax Parkinson's Disease Product Offered

11.7.3 Amneal + Impax Parkinson's Disease Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Amneal + Impax Main Business Overview

11.7.5 Amneal + Impax Latest Developments

11.8 Lundbeck

11.8.1 Lundbeck Company Information

11.8.2 Lundbeck Parkinson's Disease Product Offered

11.8.3 Lundbeck Parkinson's Disease Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Lundbeck Main Business Overview

11.8.5 Lundbeck Latest Developments

11.9 Sun Pharma

11.9.1 Sun Pharma Company Information

11.9.2 Sun Pharma Parkinson's Disease Product Offered

11.9.3 Sun Pharma Parkinson's Disease Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Sun Pharma Main Business Overview

11.9.5 Sun Pharma Latest Developments

11.10 Wockhardt

11.10.1 Wockhardt Company Information

11.10.2 Wockhardt Parkinson's Disease Product Offered

11.10.3 Wockhardt Parkinson's Disease Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Wockhardt Main Business Overview

11.10.5 Wockhardt Latest Developments

11.11 UCB

11.11.1 UCB Company Information

11.11.2 UCB Parkinson's Disease Product Offered

11.11.3 UCB Parkinson's Disease Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 UCB Main Business Overview

11.11.5 UCB Latest Developments

11.12 Bausch Health

11.12.1 Bausch Health Company Information

11.12.2 Bausch Health Parkinson's Disease Product Offered

11.12.3 Bausch Health Parkinson's Disease Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Bausch Health Main Business Overview

11.12.5 Bausch Health Latest Developments

11.13 Acadia

11.13.1 Acadia Company Information

11.13.2 Acadia Parkinson's Disease Product Offered

11.13.3 Acadia Parkinson's Disease Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Acadia Main Business Overview

11.13.5 Acadia Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Parkinson's Disease Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Carbidopa/Levodopa

Table 3. Major Players of Dopamine Receptor Agonists

Table 4. Major Players of MAO-Inhibitors

Table 5. Parkinson's Disease Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Parkinson's Disease Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Parkinson's Disease Market Size Market Share by Type (2017-2022)

Table 8. Parkinson's Disease Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Parkinson's Disease Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Parkinson's Disease Market Size Market Share by Application (2017-2022)

Table 11. Global Parkinson's Disease Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Parkinson's Disease Revenue Market Share by Player (2020-2022)

Table 13. Parkinson's Disease Key Players Head office and Products Offered

Table 14. Parkinson's Disease Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Parkinson's Disease Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Parkinson's Disease Market Size Market Share by Regions (2017-2022)

Table 19. Americas Parkinson's Disease Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Parkinson's Disease Market Size Market Share by Country (2017-2022)

Table 21. Americas Parkinson's Disease Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Parkinson's Disease Market Size Market Share by Type (2017-2022)

Table 23. Americas Parkinson's Disease Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Parkinson's Disease Market Size Market Share by Application (2017-2022)

Table 25. APAC Parkinson's Disease Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Parkinson's Disease Market Size Market Share by Region (2017-2022)

Table 27. APAC Parkinson's Disease Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Parkinson's Disease Market Size Market Share by Type (2017-2022)

Table 29. APAC Parkinson's Disease Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Parkinson's Disease Market Size Market Share by Application (2017-2022)

Table 31. Europe Parkinson's Disease Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Parkinson's Disease Market Size Market Share by Country (2017-2022)

Table 33. Europe Parkinson's Disease Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Parkinson's Disease Market Size Market Share by Type (2017-2022)

Table 35. Europe Parkinson's Disease Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Parkinson's Disease Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Parkinson's Disease Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Parkinson's Disease Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Parkinson's Disease Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Parkinson's Disease Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Parkinson's Disease Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Parkinson's Disease Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Parkinson's Disease

Table 44. Key Market Challenges & Risks of Parkinson's Disease

Table 45. Key Industry Trends of Parkinson's Disease

Table 46. Global Parkinson's Disease Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Parkinson's Disease Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Parkinson's Disease Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Parkinson's Disease Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Parkinson's Disease Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Parkinson's Disease Market Size Market Share Forecast by Application (2023-2028)

Table 52. Teva Details, Company Type, Parkinson's Disease Area Served and Its Competitors

Table 53. Teva Parkinson's Disease Product Offered

Table 54. Teva Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Teva Main Business

Table 56. Teva Latest Developments

Table 57. Novartis Details, Company Type, Parkinson's Disease Area Served and Its Competitors

Table 58. Novartis Parkinson's Disease Product Offered

Table 59. Novartis Main Business

Table 60. Novartis Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Novartis Latest Developments

Table 62. GSK Details, Company Type, Parkinson's Disease Area Served and Its Competitors

Table 63. GSK Parkinson's Disease Product Offered

Table 64. GSK Main Business

Table 65. GSK Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. GSK Latest Developments

Table 67. AbbVie Details, Company Type, Parkinson's Disease Area Served and Its Competitors

Table 68. AbbVie Parkinson's Disease Product Offered

Table 69. AbbVie Main Business

Table 70. AbbVie Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. AbbVie Latest Developments

Table 72. Merck Details, Company Type, Parkinson's Disease Area Served and Its Competitors

Table 73. Merck Parkinson's Disease Product Offered

Table 74. Merck Main Business

Table 75. Merck Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Merck Latest Developments

Table 77. Boehringer Ingelheim Details, Company Type, Parkinson's Disease Area Served and Its Competitors

Table 78. Boehringer Ingelheim Parkinson's Disease Product Offered

Table 79. Boehringer Ingelheim Main Business

Table 80. Boehringer Ingelheim Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Boehringer Ingelheim Latest Developments

Table 82. Amneal + Impax Details, Company Type, Parkinson's Disease Area Served and Its Competitors

Table 83. Amneal + Impax Parkinson's Disease Product Offered

Table 84. Amneal + Impax Main Business

Table 85. Amneal + Impax Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Amneal + Impax Latest Developments

Table 87. Lundbeck Details, Company Type, Parkinson's Disease Area Served and Its Competitors

Table 88. Lundbeck Parkinson's Disease Product Offered

Table 89. Lundbeck Main Business

Table 90. Lundbeck Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Lundbeck Latest Developments

Table 92. Sun Pharma Details, Company Type, Parkinson's Disease Area Served and Its Competitors

Table 93. Sun Pharma Parkinson's Disease Product Offered

Table 94. Sun Pharma Main Business

Table 95. Sun Pharma Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Sun Pharma Latest Developments

Table 97. Wockhardt Details, Company Type, Parkinson's Disease Area Served and Its Competitors

Table 98. Wockhardt Parkinson's Disease Product Offered

Table 99. Wockhardt Main Business

Table 100. Wockhardt Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Wockhardt Latest Developments

Table 102. UCB Details, Company Type, Parkinson's Disease Area Served and Its Competitors

Table 103. UCB Parkinson's Disease Product Offered

Table 104. UCB Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. UCB Main Business

Table 106. UCB Latest Developments

Table 107. Bausch Health Details, Company Type, Parkinson's Disease Area Served and Its Competitors

Table 108. Bausch Health Parkinson's Disease Product Offered

Table 109. Bausch Health Main Business

Table 110. Bausch Health Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. Bausch Health Latest Developments

Table 112. Acadia Details, Company Type, Parkinson's Disease Area Served and Its Competitors

Table 113. Acadia Parkinson's Disease Product Offered

Table 114. Acadia Main Business

Table 115. Acadia Parkinson's Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Acadia Latest Developments

List of Figures

Figure 1. Parkinson's Disease Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Parkinson's Disease Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Parkinson's Disease Market Size Market Share by Type in 2021

Figure 7. Parkinson's Disease in Hospitals

Figure 8. Global Parkinson's Disease Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Parkinson's Disease in Clinics

Figure 10. Global Parkinson's Disease Market: Clinics (2017-2022) & ($ Millions)

Figure 11. Global Parkinson's Disease Market Size Market Share by Application in 2021

Figure 12. Global Parkinson's Disease Revenue Market Share by Player in 2021

Figure 13. Global Parkinson's Disease Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Parkinson's Disease Market Size 2017-2022 ($ Millions)

Figure 15. APAC Parkinson's Disease Market Size 2017-2022 ($ Millions)

Figure 16. Europe Parkinson's Disease Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Parkinson's Disease Market Size 2017-2022 ($ Millions)

Figure 18. Americas Parkinson's Disease Value Market Share by Country in 2021

Figure 19. Americas Parkinson's Disease Consumption Market Share by Type in 2021

Figure 20. Americas Parkinson's Disease Market Size Market Share by Application in 2021

Figure 21. United States Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Parkinson's Disease Market Size Market Share by Region in 2021

Figure 26. APAC Parkinson's Disease Market Size Market Share by Application in 2021

Figure 27. China Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Parkinson's Disease Market Size Market Share by Country in 2021

Figure 34. Europe Parkinson's Disease Market Size Market Share by Type in 2021

Figure 35. Europe Parkinson's Disease Market Size Market Share by Application in 2021

Figure 36. Germany Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Parkinson's Disease Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Parkinson's Disease Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Parkinson's Disease Market Size Market Share by Application in 2021

Figure 44. Egypt Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Parkinson's Disease Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 50. APAC Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 51. Europe Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 53. United States Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 54. Canada Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 57. China Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 58. Japan Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 59. Korea Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 61. India Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 62. Australia Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 63. Germany Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 64. France Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 65. UK Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 66. Italy Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 67. Russia Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 68. Spain Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 71. Israel Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Parkinson's Disease Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Parkinson's Disease Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450